Latest Insider Transactions at Context Therapeutics Inc. (CNTX)
This section provides a real-time view of insider transactions for Context Therapeutics Inc. (CNTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Context Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Context Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 21
2023
|
Martin A. Lehr Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,823
+3.52%
|
$0
$0.84 P/Share
|
Feb 13
2023
|
Martin A. Lehr Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,606
+3.52%
|
$0
$0.87 P/Share
|
Feb 06
2023
|
Martin A. Lehr Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,040
+3.29%
|
$0
$0.97 P/Share
|
Jan 30
2023
|
Martin A. Lehr Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
7,027
+4.68%
|
$0
$0.7 P/Share
|
Jan 23
2023
|
Martin A. Lehr Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
6,839
+4.78%
|
$0
$0.72 P/Share
|
Jan 17
2023
|
Martin A. Lehr Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
6,783
+4.98%
|
$0
$0.74 P/Share
|
Dec 16
2022
|
Martin A. Lehr Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+14.03%
|
$0
$0.74 P/Share
|
Dec 16
2022
|
Jennifer Lynn Minai Azary Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
25,000
+38.46%
|
$0
$0.74 P/Share
|
Dec 09
2022
|
Alex C. Levit Chief Legal Officer, Corp. Sec |
BUY
Open market or private purchase
|
Direct |
6,000
+40.0%
|
$0
$0.85 P/Share
|
Aug 19
2022
|
Martin A. Lehr Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
13,000
+11.25%
|
$13,000
$1.85 P/Share
|
Aug 17
2022
|
Jennifer Lynn Minai Azary Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+50.0%
|
$15,000
$1.8 P/Share
|
Aug 16
2022
|
Tarek Sahmoud Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$10,000
$1.95 P/Share
|
Dec 16
2021
|
Martin A. Lehr Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
13,000
+1.56%
|
$39,000
$3.22 P/Share
|
Oct 22
2021
|
Evan G. Dick |
BUY
Conversion of derivative security
|
Direct |
26,587
+23.38%
|
-
|
Oct 22
2021
|
Martin A. Lehr Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
797,198
+42.64%
|
-
|
Oct 22
2021
|
Martin A. Lehr Chief Executive Officer |
BUY
Exercise of out-of-the-money derivative securities
|
Indirect |
52,680
+50.0%
|
$368,760
$7.14 P/Share
|
Oct 22
2021
|
Martin A. Lehr Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+9.13%
|
$50,000
$5.0 P/Share
|
Oct 22
2021
|
Alex C. Levit Chief Legal Officer, Corp. Sec |
BUY
Open market or private purchase
|
Direct |
3,000
+50.0%
|
$15,000
$5.0 P/Share
|